Category Archives: Testosterone Replacement Therapy

Global Testosterone Replacement Therapy Market presenting the fundamental market overview, market trends, past, present and forecast data related to the Testosterone Replacement Therapy Market From 2020-2025. A complete analysis of the Testosterone Replacement Therapy based on the definition, product specifications, market gains, key geographic regions, and imminent Testosterone Replacement Therapy players will drive key business decisions.

Global Testosterone Replacement Therapy market report presents a thorough and latest market insights in the form of graphs, pie charts, tables to provide a clear picture of the Testosterone Replacement Therapy Market. Global Testosterone Replacement Therapy report is divided into different chunks based on the type, diverse applications, key geographical regions, market share of each player, their production volume, and supply-demand ratio.

Dont Miss Out On Business Opportunities In Testosterone Replacement Therapy Market | Get FREE Sample Pages At: @ https://www.eonmarketresearch.com/sample/58743

Global Testosterone Replacement Therapy Market Report is Segmented Into Different Parts As Below:

Testosterone Replacement Therapy Market Details Based On Key Players:

AbbVieAllerganBayerEli Lilly and CompanyKyowa Kirin InternationalNovartisPfizer

Testosterone Replacement Therapy Market Based On Product Type:

General Type

Testosterone Replacement Therapy Market Based On Product Applications:

Medical

In this study, the years examined to evaluate the market size of Testosterone Replacement Therapy are as per follows:

History Year: 2014-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2020 to 2025

Inquiry before Buying Testosterone Replacement Therapy Market 2020 Report and Ask For Discount Here @ https://www.eonmarketresearch.com/enquiry/58743

The Global Testosterone Replacement Therapy Market Report Covers The Following Data Points:

Section 1: This section covers the Global Testosterone Replacement Therapy Market overview, including the basic market introduction, market analysis by its applications, type, and regions. The major regions of the Global Testosterone Replacement Therapy Market include, Europe, Asia, Middle East & Africa. Testosterone Replacement Therapy Market statistics and outlook (2020-2025) are presented in this section. Testosterone Replacement Therapy market dynamics states the opportunities, key driving forces, market risk are studied.

Section 2: This section covers Testosterone Replacement Therapy manufacturers profile based on their business overview, product type, and application. Also, the sales volume, Testosterone Replacement Therapy product price, gross margin analysis, and Testosterone Replacement Therapy market share of each player is profiled in this report.

Section 3 and Section 4: These sections present the Testosterone Replacement Therapy competition based on sales, profits, and market division of each manufacturer. It also covers the Testosterone Replacement Therapy market scenario based on regional conditions. Region-wise Testosterone Replacement Therapy sales and growth (2020-2025) are studied in this report.

Section 5 and Section 6: These two sections cover the Testosterone Replacement Therapy Market by countries. Under this, the Testosterone Replacement Therapy revenue, the market share of the countries like United States, Canada & Mexico are provided.

Section 7, Section 8 and Section 9: These 3 sections covers Testosterone Replacement Therapy sales revenue and growth in all the regions. Under these regions Testosterone Replacement Therapy report covered, the growth and sales in these regions are illustrated in this Testosterone Replacement Therapy Market report.

Section 10 and Section 11: These sections depict the Testosterone Replacement Therapy market share, revenue, sales by product type and application. The Testosterone Replacement Therapy sales growth seen during 2015-2020 is covered in this report.

Section 12 and Section 13: These sections provide forecast information related to Testosterone Replacement Therapy market (2020-2025) for each region. The sales channels include direct and indirect Testosterone Replacement Therapy marketing, traders, distributors, and development trends are presented in this report.

Section 14 and Section 15: In these sections, Testosterone Replacement Therapy market key research conclusions and outcome, analysis methodology, and data sources are covered.

*** Thank you for reading. You may also request custom information, such as chapter-wise or unique region-wise research, depending on your interest. ***

Contact Us:

Eon Market ResearchPhone: +1 703 879 7090Email: sales@eonmarketresearch.com

Read more:
Global Testosterone Replacement Therapy Market Research Report By Key Players, Geographical Regions and Growth Analysis Outlook Up To 2025 - Fashion...

If you follow enough trans women on Twitter, you might have seen a panic break out earlier this week over concerns that spironolactone, a testosterone blocker that many of us take as part of hormone replacement therapy that is also widely prescribed to the general population to treat hormonal acne, increases ones risk for developing COVID-19. Thankfully, according to the medical experts VICE spoke with, there is absolutely no cause for concern.

The mess, like many before it, all began on Instagram. Ellen Marmur, a New York City dermatologist, posted a video to her feed on March 21 in which she recommends that her patients stop taking spironolactone, also called spiro. The potassium-sparing diuretic was initially developed in 1957 to treat hypertension and congestive heart failure.

I would stop spironolactone, Marmur says in the video. It is not medically necessary for acne. I am only talking about my acne patients. I would stop the spironolactone until we know further.

As Marmur explains in the video, her recommendation is based on her own research into spironolactones effect on angiotensin converting enzyme 2 (ACE2) receptors, which appear to serve as one possible entry point for SARS-CoV-2, the novel coronavirus that can cause COVID-19. This is not a recommendation shared by the American Academy of Dermatology, she notes at the top of the clip; she merely speaks for herself. A number of outlets ran with the recommendation shortly after Marmur posted the video to her Instagram account, which has nearly 16,000 followers at press time. Pop Sugar and RealSelf told readers that they might want to stop taking spiro as a precautionary measure against COVID-19. Neither site makes note of the key role spiro plays in trans healthcare, nor does Marmur in her Instagram video.

In the days that followed, an increasing number of trans people started sharing the RealSelf and Pop Sugar articles on social media, anxiously wondering whether a medication that many consider to be life-saving may actually be putting their lives at risk. The concern is more than valid. Trans healthcare and its impact on actual trans people has been woefully under-researched since its inception, leading many trans individuals to trust anecdotal information from other community members as much as if not more than the recommendations they get directly from providers. Given our constantly evolving understanding of the coronavirus pandemic, not to mention spiros negative reputation in many pockets of the community, we would have every reason to worry after reading RealSelf or Pop Sugars alarming and, frankly, irresponsible reporting.

VICE spoke with medical providers who oversee trans healthcare and other services at two LGBTQ community health centers, both of whom agreed that there is no reason to believe that taking spiro will make any individual, trans or cis, any more susceptible to COVID-19. The data is still inconclusive regarding the role of ACE2 receptors and coronavirus susceptibility, said Julie Thompson, Medical Director of Trans Health at Fenway Health in Boston. Asa Radix, Senior Director of Research and Education at Callen-Lorde Community Health Center in New York City, echoed Thompsons sentiments: I would not want someone to stop the medication based on no evidence.

The argument that spiro might make one more vulnerable to the virus may appear to be scientifically sound at first, with many credible citations to back it up. But in the words of Cher Horowitz, its a full-on Monet: From far away its OK, but up close? Its a big old mess. Marmurs claim likely draws on a study from 2005 about how spiro increases the activity and expression of your cells ACE2 receptors, which, as discussed earlier, are believed to be key to the novel coronavirus replication process. (Radix was skeptical about this study during our interview, noting that it only involved 10 patients.) Using a kind of transitive logic, the people making the case against spiro then connect that studys findings to current research into whether medications that affect ACE2 receptors might increase risk for COVID-19 infection. In other words, if A equals B and B equals C, then spiro might make you more susceptible to COVID-19.

The problem here is that no matter how scary that risk sounds, its still theoretical. Nobody has conclusively proven that taking spiro, or any other medication that affects our ACE2 receptors, will make us more likely to get infected. And given how long it would take to conduct a study and produce any credible evidence one way or the other, nobody will be able to conclusively prove it any time soon.

On March 17, the American Heart Association, the American College of Cardiology, and the Heart Failure Society of America released a joint statement addressing concerns about ACE2 receptor-interactant medications and COVID-19 risk, telling patients to continue taking ACE inhibitors and angiotensin-receptor blockers (ARBs) as prescribed. Radix of Callen-Lorde told VICE that trans people currently taking spiro should continue to do so, as well. Rather than worry about a theoretical risk, he recommended that we instead focus our attention on the very real health risks trans people will face in this pandemic.

Trans people have always had inadequate healthcare and are generally discriminated against in our systems, all of which will continue, he said. Imagine if you were a trans person whod had negative healthcare experiences, and you developed COVID-19. Youre probably sitting at home and worrying about whether you should even go to the emergency room. Those are the issues we should be concerned about: encouraging trans people to seek out healthcare if they need it.

Thats not theoretical. Thats real.

Sign up for our newsletter to get the best of VICE delivered to your inbox daily.

Follow Harron Walker on Twitter .

Here is the original post:
A Dermatologist Is Creating Unnecessary Panic Around Spironolactone and COVID-19 - VICE

Financing to speed commercialization of the only FDA-approved oral treatment of its kind for testosterone deficiency1,2

NORTHBROOK, Ill., March 16, 2020 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc., a commercial mens health specialty pharmaceutical company, announced today that it has completed a senior debt financing of up to $75M. Morgan Stanley & Co. LLC acted as sole placement agent for the transaction.

Clarus will use the proceeds from this financing to accelerate the commercialization strategy and launch for JATENZO (testosterone undecanoate) capsules, CIII, the first and only FDA-approved oral softgel testosterone replacement therapy for the treatment of men with hypogonadism due to certain medical conditions. This additional investment builds on an exceptional year for the company, which includes hiring multiple key executives and making JATENZO available for patients.

We are thrilled to have this investment as we bring JATENZO to market, said Dr. Robert Dudley, Chief Executive Officer of Clarus Therapeutics, Inc. We can now fully implement JATENZOs commercialization strategy and move Clarus closer to profitability.

About HypogonadismHypogonadism, also known as testosterone deficiency, is a condition in men in which the body does not produce enough testosterone.3 Only those men who are symptomatic and have consistently low results on a reliable testosterone assay should be offered testosterone replacement therapy, according to current treatment guidelines from both the Endocrine Society and the American Urological Association.3,4 Treatment is meant to induce and maintain secondary sex characteristics and improve clinical symptoms associated with testosterone deficiency.4About Clarus Therapeutics, Inc.Clarus is a men's specialty pharmaceutical company developing and commercializing JATENZO, a product protected by patents issued in the United States and in other major pharmaceutical markets around the world. Clarus owns the worldwide, royalty-free commercialization rights for JATENZO.For more information, please visit:www.clarustherapeutics.com.

About JATENZO JATENZO is the first and only FDA-approved oral testosterone undecanoate for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone: primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired).1,2

JATENZOs proprietary formulation is built around testosterone undecanoatea testosterone prodrug that the body converts to testosterone. In the JATENZO pivotal inTUne (investigational testosterone undecanoate) clinical trial, 87 percent of hypogonadal men treated with JATENZO achieved a mean total testosterone concentration in the eugonadal range at the end of treatment.1 The efficacy and safety of JATENZO was evaluated in 166 adult, hypogonadal males in a 4-month, open-label study. The primary endpoint was the percentage of patients with mean plasma total testosterone concentration (Cavg) over 24 hours within the normal eugonadal range on the final pharmacokinetic visit of the study.

INDICATIONJATENZO (testosterone undecanoate) capsules, CIII, is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone:

Limitation of use

Safety and efficacy of JATENZO in males less than 18 years old have not been established.

IMPORTANT SAFETY INFORMATION

WARNING: INCREASES IN BLOOD PRESSURE

CONTRAINDICATIONS

JATENZO is contraindicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate, in women who are pregnant, in men with a known hypersensitivity to JATENZO or its ingredients, or in men with hypogonadal conditions that are not associated with structural or genetic etiologies as JATENZO has not been established for these conditions and there is a risk of increased blood pressure with JATENZO that can increase the risk of MACE.

WARNINGS AND PRECAUTIONS

ADVERSE EVENTS

The most common adverse events of JATENZO (incidence 2%) are headache (5%), increased hematocrit (5%), hypertension (4%), decreased HDL (3%), and nausea (2%).

DRUG INTERACTIONS

USE IN SPECIFIC POPULATIONS

Story continues

The safety and efficacy of JATENZO in pediatric patients less than 18 years old have not been established. Improper use may result in acceleration of bone age and premature closure of epiphyses.

There have not been sufficient numbers of geriatric patients involved in controlled clinical studies utilizing JATENZO to determine whether efficacy or safety in those over 65 years of age differs from younger subjects. There is insufficient long-term safety data in geriatric patients utilizing JATENZO to assess the potentially increased risk of cardiovascular disease and prostate cancer.

Please click here for full Prescribing Information, including BOXED WARNING on increases in blood pressure.

Media ContactAmir KhanPhone: (212) 462-8767Email: Amir.Khan@Syneoshealth.com

1JATENZO (testosterone undecanoate) [prescribing information]. Clarus Therapeutics, Inc.

2US Food & Drug Administration. FDA Approved Drug Products. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206089. Accessed October 1, 2019.

3Bhasin S, et al. J Clin Endocrinol Metab. 2018;103(5):1715-1744.

4Mulhall JP, et al. J Urol. 2018;200(2):423-432.

2020 Clarus Therapeutics, Inc. All rights reserved.

JATENZO is a registered trademark of Clarus Therapeutics, Inc.

COR-US-0038 03/2020

Go here to see the original:
CLARUS THERAPEUTICS ANNOUNCES FINANCING TO SUPPORT THE COMMERCIAL LAUNCH AND AVAILABILITY OF JATENZO (TESTOSTERONE UNDECANOATE) CAPSULES, CIII FOR THE...

Testosterone therapy is intended to treat male hypogonadism (low testosterone or Low T), a condition in which the body fails to make enough hormones because of a problem with the testicles, pituitary gland or brain. A number of prescription testosterone products are available to treat hypogonadism.Testosterone productscome in different forms, including gels, injectable solutions, patches, pills and pellets implanted under the skin.

Once a patient starts testosterone therapy, the patient usually undergoes lifelong treatment. Doctors will monitor the patients hormone levels every six months to a year. Depending on the patient, the checkups may be more frequent.

Fast Facts: Use of Testosterone Therapy Over the Years

Testosterone can be administered in skin patch, skin gel, pill or cream form or as an injection, a solution applied to the armpit or a patch or a buccal system applied to the upper gum or inner cheek.

While many testosterone products areavailable only with a prescription, some drug stores and health food stores sell them over the counter. A few of these products also claim to be all-natural.

Testosterone gel is a prescription medication applied directly to a mans skin on the shoulders and upper arms and/or abdomen, depending on the brand. Testosterone gel can inadvertently transfer from your body to others and can lead to serious health reactions. To avoid such contact, apply testosterone gel to clean, dry, intact skin that will be covered by clothing. Wash your hands right away with soap and water after applying. Once the gel has dried, cover the area with clothing and keep it covered until you have washed the area well or have showered.

First approved in 1979, Depo-testosterone is one of the older drugs of its kind on the market. Its a liquid and is designed for injection deep into the gluteal muscle. The active ingredient, testosterone cypionate, is a white or creamy white powder mixed with other ingredients to make a solution. The drug is available in two strengths, 100 mg and 200 mg.

Testosterone transdermal patches, including Androderm, come as patches to apply to the skin. Patches work best when applied around the same time each night and are left in place for 24 hours. Testosterone patches are meant to be worn at all times until replaced with new patches. Androderm patches should be changed every 24 hours. The old patch should be removed before applying the new one. You should apply the patches to different spots each night and wait at least seven days before re-using a spot.

The testosterone capsules Methyltestosterone and Android have been discontinued but have been used in men and boys to treat conditions caused by lack of hormone, such as delayed puberty, and in women to treat breast cancer that has spread to other parts of the body. Methyltestosterone is a man-made form of testosterone. It can affect bone growth in boys who are treated for delayed puberty.

Manufacturers of testosterone boosters like Testofen have touted their products as means to increase muscle mass, strength and sex drive in men. Among the most popular testosterone boosters are products that contain some combination of tribulus terrestris, DHEA, zinc and d-aspartic acid. These ingredients have been associated witha number of side effects, including aggressiveness, breast enlargement, cholesterol changes, prostate problems and an increased risk of cardiovascular disease.

Makers of testosterone products use two types of hormones:

Bioidentical HormonesAndroGel and a number of other products contain bioidentical hormones. Scientists create bioidentical hormones in a lab to chemically match the hormone naturally made by the body. In theory, this results in fewer side effects.

Synthetic HormonesSynthetic hormones are altered from the original chemical makeup, so they do not match those made by the body. These types of drugs typically have more side effects.

Unusually high or low levels of testosterone can significantly affect a mans physical and mental health. Men typically use testosterone drugs to address a medical issue like Low T or erectile dysfunction or to enhance their physical performance

Testosterone levels in men start to spike during puberty and drop on average by 1 percent every year after age 30. Lack of this key sex hormone in older men can cause health issues, including osteoporosis, loss of muscle mass and strength (sarcopenia), and psychological symptoms. Doctors prescribe testosterone drugs to treat these symptoms.

While declining testosterone levels tend to be part of normal aging in men, others experience the dip because of disorders of the testicles, pituitary gland and brain that cause hypogonadism. Other factors such as injury to the testicles, cancer treatments, chronic diseases and stress can also contribute to low testosterone production.

TheFDAapproved testosterone as replacement therapy only for men who have low testosterone levels due to disorders that cause hypogonadism. However, the agency has said testosterone is being widely used to try to relieve symptoms in men who have low testosterone for no apparent reason other than aging a use for which the benefits and safety have not been established.

Doctors analyze testosterone levels in two categories: total testosterone and free testosterone. Most testosterone is attached to a protein called sex hormone-binding globulin (SHGB). A small amount of testosterone is free, and a small amount regularly attaches and detaches itself from a protein called albumin. Any testosterone that is not attached to SHGB is considered free testosterone.

Some men turn to testosterone to increase sex drive and treat erectile dysfunction (ED), which is the inability to get and keep erections. In fact, according to an article published by Harvard Health Publications, some doctors used it to treat ED beforePfizerreleased Viagra in 1998.

Its well established that testosterone by itself, for men with sexual dysfunction that includes erectile dysfunction, can improve erections in the majority of men who take it.

However, only about 5 percent of men experience ED solely from low testosterone. Low testosterone levels can be a contributing factor to ED but are more likely to reduce sexual desire than cause ED. Many doctors wont consider prescribing testosterone to a patient unless he presents certain other symptoms, too.

Dr. Abraham Morgentaler is an advocate of using testosterone for treating men with sexual dysfunction, including ED.

Morgentaler does admit that some men may require testosterone andViagra, however, in order to have adequate erections.

Because testosterone allows men to increase muscle mass and performance, athletes and body builders use testosterone-boosting supplements and drugs to increase strength and improve recovery time. The practice of using these drugs is called doping. Athletes use both synthetic and bioidentical supplements. Body builders in particular are known for their use of synthetic hormones to rapidly increase muscle mass.

Testosterone can help increase muscle mass in a much faster fashion. Athletes who use anabolic steroids may find that theyre able to increase their endurance and their strength by doing the same amount of training as they would otherwise, Dr. Anthony Yin, an endocrinologist at California Pacific Medical Center in San Francisco, told SF Gate.

However, using performance-enhancing drugs, testosterone included, is illegal in most sports. While the drug is helpful to men who are clinically diagnosed with Low T, men who abuse these drugs solely to boost performance face a number of possible side effects.

As use of testosterone therapy has increased so has the amount of concern surrounding these products.

Some doctors say that in reality, few men are actually diagnosed with clinical hypogonadism, and that many symptoms are just a normal part of aging. A study published in the Journal of Clinical Endocrinology & Metabolism shows record numbers of men in the U.S. are turning to testosterone therapy simply to increase their sex drive and energy levels.

Critics say that Low T is a conditionmarketed by drug companiesto increase profits. Doctors are concerned that the long-term effects have not yet been properly studied and feel there should be more agreement about what constitutes a normal testosterone level. Because testosterone therapies are not proven treatments, they caution that risks may outweigh benefits forhealthy men.

Dr. Lisa Schwartz, a professor at the Dartmouth Institute for Health Policy and Clinical Practice, wrote a paper on drug companies marketing these hormone therapies.

Were giving people hormones that we dont know they need for a disease that we dont know they have, and we dont know if itll help them or harm them.

Over the years, men havesued the makers of testosterone productsafter using the therapies and suffering from heart attacks, strokes and blood clots. Meanwhile, researchers have conducted studies to better understand the effects of testosterone therapy.

Researchers for a year studied the effect of testosterone treatment on cognition, bone health, anemia and cardiovascular health in 788 men aged 65 or older who had low testosterone levels that couldnt be explained by anything other than age.

According to the findings, reported in February 2017 in JAMA and JAMA Internal Medicine, testosterone treatment did not have an effect on memory or cognitive abilities, though it appeared to increase hemoglobin levelsin men with anemia and improve bone density. In addition, a clinical trial found one year of testosterone treatment in men aged 65 or older with Low T was associated with a significant increase in coronary artery plaque, a risk factor for heart disease.

Studies have linked testosterone products to serious side effects, prompting the FDA to take action in recent years towarn the publicof the potential dangers of these products.

Testosterone therapy is associated with an increased risk for these health problems:

Testosterone therapy for men can be dangerous to women and children if they come in contact with the drug by touching the patients skin. This usually occurs when men use testosterone gel and the application site is exposed. Anyone who comes in contact with the application site is at risk of developing side effects.

Women can experience acne or hair growth, and if they are pregnant, the unborn baby may be harmed.

In 2009, the FDA issued a warning about adverse effects in children exposed to testosterone gels through contact with application sites. Symptoms included abnormally large genitalia (penis and clitoris), advanced bone age, early puberty and aggressive behavior. Young boys may even develop enlarged breasts. A doctor should be contacted right away if these symptoms occur.

Pets exposed to testosterone can become violent and aggressive and develop enlarged genitals.

Read more here:
Testosterone Therapy Treatment Types, Uses & Risks

Testosterone Replacement Therapy Market 2018: Global Industry Insights by Global Players, Regional Segmentation, Growth, Applications, Major Drivers, Value and Foreseen till 2024

The report provides both quantitative and qualitative information of global Testosterone Replacement Therapy market for period of 2018 to 2025. As per the analysis provided in the report, the global market of Testosterone Replacement Therapy is estimated to growth at a CAGR of _% during the forecast period 2018 to 2025 and is expected to rise to USD _ million/billion by the end of year 2025. In the year 2016, the global Testosterone Replacement Therapy market was valued at USD _ million/billion.

This research report based on Testosterone Replacement Therapy market and available with Market Study Report includes latest and upcoming industry trends in addition to the global spectrum of the Testosterone Replacement Therapy market that includes numerous regions. Likewise, the report also expands on intricate details pertaining to contributions by key players, demand and supply analysis as well as market share growth of the Testosterone Replacement Therapy industry.

Request Sample Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2611333&source=atm

Testosterone Replacement Therapy Market Overview:

The Research projects that the Testosterone Replacement Therapy market size will grow from in 2018 to by 2024, at an estimated CAGR of XX%. The base year considered for the study is 2018, and the market size is projected from 2018 to 2024.

Leading manufacturers of Testosterone Replacement Therapy Market:

The major players profiled in this report include:AbbVieAllerganBayer Eli Lilly and CompanyKyowa Kirin InternationalNovartis Pfizer

The end users/applications and product categories analysis:On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-General Type

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Testosterone Replacement Therapy for each application, including-Medical

Make An EnquiryAbout This Report @ https://www.researchmoz.com/enquiry.php?type=E&repid=2611333&source=atm

Some important highlights from the report include:

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2611333&licType=S&source=atm

The Questions Answered by Testosterone Replacement Therapy Market Report:

And Many More.

Read more here:
Testosterone Replacement Therapy Market Organization Sizes Analysis 2019-2025 - Packaging News 24

There are many positive benefits of testosterone therapy. While testosterone is the male hormone, and testosterone replacement therapy is most often used to treat men with low testosterone, you may be surprised to learn that women can benefit from testosterone therapy as well.

Even though testosterone is an androgen, or male hormone, womens bodies do make and need testosterone, albeit, not as much as men, and for different things than men do. Unlike being necessary in vast amounts to provide for the development of maleness in men, in women, testosterone is necessary for:

When a women is experiencing low testosterone, all of the above can be negatively affected.

As in men, a womans testosterone level can fluctuate throughout the day, and can be impacted by many things from diet to her menstrual cycle. However, as in their male counterparts, the most significant drain on testosterone levels in women, occurs from the impact of ageing.

When you think about hormone replacement therapy (HRT) for women, the first thought that usually comes to mind is the typical estrogen therapy that is used to treat menopausal symptoms. However, when a woman is going through menopause, along with estrogen depletion, she is also losing her ability to produce adequate amounts of testosterone. A woman with low testosterone, will have trouble producing new blood cells, maintaining her libido or sex drive, and will find it harder to build muscle and burn fat.

When this is the case she will show the signs of low testosterone. The signs and symptoms of low testosterone in woman include:

Current research indicates that women who are on estrogen replacement for menopausal symptoms, can also benefit when testosterone therapy is added as an adjunct to estrogen replacement in these women. Testosterone, when used in this way, seems to specifically help with the sexual wellness issues typical of post-menopausal women. According to Dr. Alan Malabanan, assistant professor of medicine at Harvard Medical School, Studies of postmenopausal women have found that taking testosterone (often in addition to the hormone therapy women are already taking to treat menopause symptoms) increases sexual desire and pleasure compared with a placebo (inactive treatment).

In addition to helping women with the sexual health issues that often occur as they age, and testosterone levels drop, testosterone therapy has also been shown to help women in other matters of overall health and wellness. One of the most widely respected studies showing testosterones importance in maintaining a womans general health as well as sexual satisfaction was published in 2000 in the New England Journal of Medicine. Using traditionally accepted randomized, double-blind, placebo-controlled methodology, this study concluded that, transdermal testosterone improves sexual function and psychological well-being. Transdermal testosterone is a form of testosterone replacement therapy that is given using transdermal (skin) patches.

In addition to increasing the libido, and increasing health and vitality overall, testosterone therapy in women can also:

Testosterone is vital to the strength, vitality, and wellbeing of both men and women. However, in women, testosterone therapy must be given with particular care. In women, testosterone therapy is rarely given alone, but is prescribed as part of an overall program of Hormone Replacement Therapy (HRT) designed to bring all of her hormones back into proper balance.

Therefore it is imperative that any women who thinks that she may benefit from testosterone therapy, seek her treatment from a doctor, or HRT clinic that is skilled and experienced. This way, she can be sure that she will be getting the very best testosterone therapy tailored to her unique needs, body, and lifestyle.

Excerpt from:
Testosterone Replacement Therapy for Women: Pros and Cons

The Global Testosterone Replacement Therapy Market 2020 Industry Trends and Forecasts to 2025 is a professional and in-depth study on the current state of the Testosterone Replacement Therapy market. Annual estimates and forecasts are provided for the period 2020 through 2025. Also, a six-year historic analysis is presented for these Testosterone Replacement Therapy businesses. The global market for Testosterone Replacement Therapy is presumed to reach about xx by 2025 from xx in 2020, joining a Compound Annual Growth Rate (CAGR) of xx % during the analysis years, 2020-2025.

The report presents a primary overview of the Testosterone Replacement Therapy industry including definitions, classifications, applications, and business chain structure. And developing strategies and programs are addressed as well as manufacturing methods and cost formations.

Click here!!!! To Download Free PDF Illustrative Brochure (Contains- Keyplayers, Growth Value, Segments, etc) @ https://www.eonmarketresearch.com/sample/58743

This report analyzing Testosterone Replacement Therapy centers on Top Companies in the global market, with capacity, production, value, income, and market share for each manufacturer, including

AbbVieAllerganBayerEli Lilly and CompanyKyowa Kirin InternationalNovartisPfizer

Global Testosterone Replacement Therapy Market 2020: Product Type Segment Analysis

General Type

Global Testosterone Replacement Therapy Market 2020: Applications Segment Analysis

Medical

Then, the Testosterone Replacement Therapy market study report concentrates on global higher leading business players with knowledge such as company profiles, product picture and specifications, sales, market share, and association information. Whats more, the Testosterone Replacement Therapy industry development trends and marketing channels are examined.

Market Segment by Regions, this report splits Global into rare key Countries, with production, expenditure, revenue, market share, and growth rate of Testosterone Replacement Therapy in these countries, from 2020 to 2025 (forecast), similar North America, Europe, Japan, Southeast Asia, India, and China.

In a word, the Testosterone Replacement Therapy market report gives important statistics on the state of the Testosterone Replacement Therapy industry and is a helpful source of guidance and direction for companies and individuals interested in the Testosterone Replacement Therapy market.

Place An Inquiry Before Buying @ https://www.eonmarketresearch.com/enquiry/58743

Table of Contents

1. Testosterone Replacement Therapy Market Overview, Scope, Segment- by Types, Applications and Regions, World Market Size and of Testosterone Replacement Therapy and Country wise Status and Prospect (2015-2025).

2. Global Testosterone Replacement Therapy Market Competition by Manufacturers- Global Testosterone Replacement Therapy Production, Revenue and Share by Manufacturers (2018 and 2020), Testosterone Replacement Therapy Industry Competitive Situation and Trends.

3. Global Testosterone Replacement Therapy Production, Revenue (Value) by Regions (North America, EU, Japan, India, and China) (2015-2020).

4. Global Testosterone Replacement Therapy Supply (Production), Consumption, Export, Import by Nations (2015-2020).

5. Global Testosterone Replacement Therapy Production, Revenue (Value), Price Trend by Types (2015-2020).

6. Global Testosterone Replacement Therapy Market Analysis by Applications and Study of Market Drivers and Opportunities.

7. Global Testosterone Replacement Therapy Manufacturers Profiles/Analysis- Company Basic Information, Manufacturing Base and Sales Area, Testosterone Replacement Therapy Product Types, Application and Specification, Production, Revenue, Price and Gross Margin (2018 and 2020) and Business Overview.

8. Analysis of Testosterone Replacement Therapy Industrial Chain Analysis, Sourcing Strategy and Downstream Buyers.

10. In this report study Testosterone Replacement Therapy Marketing Channel, Positioning and Strategy Analysis and List of Testosterone Replacement Therapy Distributors/Traders.

11. Global Testosterone Replacement Therapy Market Production and Price Forecast by Countries, Type, and Application (2020-2025).

12. Research Findings and Conclusion.

About Us:

Eon Market Research (EMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers.

Contact Us:

Eon Market ResearchPhone: +1 703 879 7090Email: sales@eonmarketresearch.com

View post:
Testosterone Replacement Therapy Market Current Status, Historical Analysis and Forecast 2020 to 2025 - Fashion Trends News

The Testosterone Replacement Therapy Market report draws accurate insights by examining the latest and prospective industry trends, helping the readers recognize the products and services that are boosting revenue growth and profitability. The study performs a detailed analysis of all the significant factors impacting the market on a global and regional scale, including drivers, constraints, threats, challenges, prospects, and industry-specific trends. Additionally, the report cites worldwide certainties and endorsements, along with a downstream and upstream evaluation of leading participants.

To ask for a sample copy of the Testosterone Replacement Therapy Market Report, visit:https://www.reportsanddata.com/sample-enquiry-form/229

Scope of the Report:

The report focuses on the important geographies of sale of the Testosterone replacement therapy such as North America, Europe and Asia-Pacific, South America, Middle East and Africa. The entire testosterone replacement therapy market has been categorized into three segments in this report, namely- manufacturers, regions, type and application.

Reasons to Buy the Report:

For the purpose of this report, Reports and Data has segmented the Testosterone Replacement Therapy market on the basis of type, source, animal, application, and region:

In market segmentation by types of testosterone replacement therapies, the report covers

Get Discounts on the Testosterone Replacement Therapy Market Report at:https://www.reportsanddata.com/discount-enquiry-form/229

In market segmentation by applications of the testosterone replacement therapy, the report covers the following uses

Regional Outlook (Revenue in USD Million; 20162026)

Key highlights of the Testosterone Replacement Therapy market:

The report is distributed over 15 Chapters to display the analysis of the global Testosterone Replacement Therapy market.

Chapter 1 covers the Blow-Fill-Seal (BFS) technology product Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2 talks about the top manufacturers and analyses their sales, revenue and pricing decisions for the duration 2016 and 2017;

Chapter 3 displays the competitive nature of the market by discussing the competition among the top manufacturers. It dissects the market using sales, revenue and market share data for 2016 and 2017;

Chapter 4, shows the global market by regions and the proportionate size of each market region based on sales, revenue and market share of Blow-Fill-Seal (BS) technology product, for the period 2012- 2017;

Chapter 5, 6, 7, 8 and 9, are dedicated to the analysis of the key regions, with sales, revenue and market share by key countries in these regions;

Browse Table of Contents with Facts and Figures of Testosterone Replacement Therapy Market Report at: https://www.reportsanddata.com/report-detail/global-testosterone-replacement-therapy-market-by-manufacturers-countries-type-and-application-forecast-to-2022

We are grateful to you for reading our report. If you wish to find more details of the report or want a customization, contact us. You can get a detailed information of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.

Continued here:
Testosterone Replacement Therapy Market Insights with Latest Statistics and Growth Prediction to 2026 | AbbVie, Endo International, Eli lilly, Pfizer,...

The Testosterone Replacement Therapy Market report draws accurate insights by examining the latest and prospective industry trends, helping the readers recognize the products and services that are boosting revenue growth and profitability. The study performs a detailed analysis of all the significant factors impacting the market on a global and regional scale, including drivers, constraints, threats, challenges, prospects, and industry-specific trends. Additionally, the report cites worldwide certainties and endorsements, along with a downstream and upstream evaluation of leading participants.

To ask for a sample copy of the Testosterone Replacement Therapy Market Report, visit:https://www.reportsanddata.com/sample-enquiry-form/229

Breadth of the Report:

The report focuses on the important geographies of sale of the Testosterone replacement therapy such as North America, Europe and Asia-Pacific, South America, Middle East and Africa. The entire testosterone replacement therapy market has been categorized into three segments in this report, namely- manufacturers, regions, type and application.

Reasons to Buy the Report:

For the purpose of this report, Reports and Data has segmented the Testosterone Replacement Therapy market on the basis of type, source, animal, application, and region:

In market segmentation by types of testosterone replacement therapies, the report covers

Get Discounts on the Testosterone Replacement Therapy Market Report at:https://www.reportsanddata.com/discount-enquiry-form/229

In market segmentation by applications of the testosterone replacement therapy, the report covers the following uses

Regional Outlook (Revenue in USD Million; 20162026)

Key highlights of the Testosterone Replacement Therapy market:

The report is distributed over 15 Chapters to display the analysis of the global Testosterone Replacement Therapy market.

Chapter 1 covers the Blow-Fill-Seal (BFS) technology product Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2 talks about the top manufacturers and analyses their sales, revenue and pricing decisions for the duration 2016 and 2017;

Chapter 3 displays the competitive nature of the market by discussing the competition among the top manufacturers. It dissects the market using sales, revenue and market share data for 2016 and 2017;

Chapter 4, shows the global market by regions and the proportionate size of each market region based on sales, revenue and market share of Blow-Fill-Seal (BS) technology product, for the period 2012- 2017;

Chapter 5, 6, 7, 8 and 9, are dedicated to the analysis of the key regions, with sales, revenue and market share by key countries in these regions;

Browse Table of Contents with Facts and Figures of Testosterone Replacement Therapy Market Report at: https://www.reportsanddata.com/report-detail/global-testosterone-replacement-therapy-market-by-manufacturers-countries-type-and-application-forecast-to-2022

We are grateful to you for reading our report. If you wish to find more details of the report or want a customization, contact us. You can get a detailed information of the entire research here. If you have any special requirements, please let us know and we will offer you the report as you want.

Original post:
Key Emerging Trends in Testosterone Replacement Therapy Market 2020 | AbbVie, Endo International, Eli lilly, Pfizer, Others - Feed Road

High levels of the sex hormone testosterone may trigger different health problems in men and women, a new study reveals.

In women, testosterone may increase the risk for type 2 diabetes, while in men it lowers that risk. But high levels of testosterone increase the risk for breast and endometrial cancer in women and prostate cancer in men, the researchers reported.

"Our findings provide unique insights into the disease impacts of testosterone. In particular, they emphasize the importance of considering men and women separately in studies, as we saw opposite effects for testosterone on diabetes," said lead researcher Katherine Ruth, of the University of Exeter in the United Kingdom.

"Caution is needed in using our results to justify use of testosterone supplements until we can do similar studies of testosterone with other diseases, especially cardiovascular disease," Ruth explained in a University of Cambridge news release.

Dr Joel Zonszein, an emeritus professor of medicine at Albert Einstein College of Medicine in New York City, said there is a "sweet spot" of normal values for men and women. "Too much is not good, and too little is also bad," he explained.

"Testosterone supplementation is widely used in both men and women with normal values with no good evidence of benefit. Testosterone replacement in truly deficient individuals is something else," said Zonszein, who had no role in the study.

For the study, British researchers collected genetic data on more than 425 000 men and women listed in the UK Biobank. The investigators found more than 2 500 genetic variations associated with levels of testosterone and the protein that binds it sex hormone-binding globulin.

The researchers checked their results with analyses of other relevant studies and used a randomisation method to see if associations between testosterone and disease are causal.

In women, a high level of testosterone was tied to a 37% increased risk for type 2 diabetes and a 51% increased risk for polycystic ovary syndrome.

In men, however, a high testosterone level was linked to a 14% lower risk of developing type 2 diabetes, the findings showed.

"The findings in men that higher testosterone has a protective effect and reduces the risk of type 2 diabetes is news to me," Zonszein said. "This needs to be shown by other studies and its mechanism needs to be elucidated."

Dr Minisha Sood, an endocrinologist at Lenox Hill Hospital in New York City, said that testosterone may not be as protective in women because it converts to estradiol, which is related to the risk for breast cancer.

"High levels of testosterone in women have also been shown to increase visceral fat, which is linked to the components of metabolic syndrome," Sood said.

That men with high testosterone are at lower risk of developing type 2 diabetes is likely related to having more lean muscle mass, which improves insulin sensitivity and reduces the likelihood of type 2 diabetes, she said.

But Sood isn't a fan of men using testosterone supplements to ward off diabetes.

"Testosterone therapy comes with potential risks, including a high red blood cell count and higher rates of high-grade prostate cancer if a man is already predisposed to develop prostate cancer," she said.

Obese men or those with type 2 diabetes would benefit more from lifestyle changes to improve testosterone levels, namely, weight loss, healthy diet and exercise.

"This approach is preferred in that population over testosterone replacement whenever possible," Sood said.

The report was published in the journal Nature Medicine.

Image credit: iStock

See the rest here:
How high testosterone levels have different health outcomes for men and women - Health24